TREM2 deficiency was associated with reduced tumor growth in several transplantable models: MCA-derived sarcoma (MCA1956 and MCA206 cell lines), MC38 colorectal carcinoma, and PyMT breast cancer [38,78]. This evidence concerns the gene TREM2 and breast carcinoma.